The global heparin market size is expected to reach
USD 7.4 billion by 2026, according to a new report by Grand View Research, Inc.
It is projected to register a CAGR of 1.6% during the forecast period. Rising
prevalence cardiovascular disorders, deep vein thrombosis, and renal diseases
among other chronic diseases is expected to boost the growth.
According to the data published in the American
Heart Association, in 2018, approximately 92.1 million American adults were
living with some form of cardiovascular diseases. Coronary heart disease is one
of the leading cause of deaths in U.S. Furthermore, it was estimated that more
than 23.6 million deaths will be observed by 2030 due to cardiovascular
diseases.
Increasing demand for transfusion of blood, blood
components, and plasma derivatives during surgical procedures, treatment of
infectious diseases, and increasing survival rate are high impact rendering
drivers for growth of the heparin market during the forecast period. Increasing
demand for RBCs and platelets by various hospital divisions and clinics is
expected to have a positive impact on the growth.
Growing geriatric population is anticipated to
propel the market growth. According to an article published in 2018 in the
United States Census Bureau, it is estimated that by 2035, population aged 65
years and above is expected to reach 78 million whereas children under the age
of 18 may reach around 76.7million.
Rising incidence of immunological diseases,
thrombosis, and hemostasis is likely to result in high demand for therapeutic
plasma proteins. Manufacturing of plasma proteins led to an increase in the
demand for purified plasma, further expected to fuel the market over the forecast period.
For More
Details Please Visit @ :
https://www.grandviewresearch.com/industry-analysis/heparin-market
https://www.grandviewresearch.com/industry-analysis/heparin-market
Further key findings from the report suggest:
·
Low molecular
weight heparin led the type segment in 2018 owing to its more predictable
anticoagulant effect
·
In 2018,
ultra-low molecular weight heparin was estimated to be the fastest growing
segment, owing to commercialization of enhanced version of products with
improved pharmacological effects
·
Subcutaneous route
of administration led the market in 2018 and is estimated to be the fastest
growing segment over the forecast period due to ease of administration
·
Coronary artery
disease was considered to be the largest application segment in 2018 and venous
thromboembolism is projected to be the fastest growing segment in near future
·
In 2018,
outpatient led the end use segment and was estimated to register the fastest
growth in the forthcoming years
·
North America
held the largest market share in 2018 owing to increasing prevalence of
cardiovascular disorders and sports injuries. Asia Pacific is estimated to be
the fastest growing segment over the forecast period
·
Some of the key
companies operating in the heparin market are GlaxoSmithKline plc; Pfizer,
Inc.; Baxter; Leo Pharma A/S; Sanofi; Dr. Reddy’s Laboratories Ltd.; Aspen
Holdings; B. Braun Medical Inc.; Fresenius SE & Co. KGaA; and Teva
Pharmaceutical Industries Ltd
Grand View Research has segmented the global
heparin market based on type, route of administration, application, end use,
and region:
Heparin Type
Form Outlook (Revenue, USD Million, 2014 - 2026)
·
Low Molecular
Weight Heparin
·
Ultra-low
Molecular Weight Heparin
·
Unfractionated
Heparin
Heparin Route of
Administration Outlook (Revenue, USD Million, 2014 - 2026)
·
Intravenous
·
Subcutaneous
Heparin
Application Form Outlook (Revenue, USD Million. 2014 - 2026)
·
Venous
Thromboembolism
·
Atrial
Fibrillation
·
Renal Impairment
·
Coronary Artery
Disease
·
Others
Heparin End Use
Outlook (Revenue, USD Million, 2014 - 2026)
·
Outpatient
·
Inpatient
Heparin Regional
Outlook (Revenue, USD Million, 2014 - 2026)
·
North America
o
U.S.
o
Canada
·
Europe
o
U.K.
o
Germany
o
France
o
Italy
o
Spain
o
Russia
·
Asia Pacific
o
Japan
o
China
o
India
o
South Korea
o
Australia
o
Singapore
·
Latin America
o
Brazil
o
Mexico
o
Argentina
·
Middle East
& Africa
o
South Africa
o
UAE
o
Saudi Arabia
Comments
Post a Comment